CD4 and celiac disease: Utilizing peptide-HLA multimer technology, antigen-specific CD4 + T cells have been demonstrated in ‘classical’ autoimmune diseases as type 1 diabetes and SLE, and also in celiac disease, Parkinson’s disease and atherosclerosis8,19–23.